CLINICAL AND PHARMACOLOGICAL DYNAMICS OF GLUCOCORTICOID THERAPY IN AUTOIMMUNE PATHOLOGIES: A MULTICENTER ANALYSIS OF EFFICACY AND SYSTEMIC TOLERANCE

Abstrak

Traditional pharmacotherapy for autoimmune conditions heavily relies on systemic immunosuppression, constantly balancing the necessity of disease remission against the severe risks of treatment-induced toxicity. This study investigates the clinical and pharmacological significance of glucocorticoid regimens in managing chronic autoimmune exacerbations, specifically focusing on their complex regulatory effects on the cellular immune response. A longitudinal analytical study was conducted to evaluate the comparative efficacy and systemic tolerance of variable glucocorticoid dosing strategies among adult patients presenting with active autoimmune manifestations. The cohort undergoing progressive dose-tapering protocols demonstrated significant clinical shifts, exhibiting rapid suppression of inflammatory cascades alongside distinct variations in metabolic stability compared to standard high-dose maintenance groups. The findings empirically demonstrate that tailored pharmacokinetic monitoring significantly optimizes the therapeutic index of steroidal agents by minimizing cumulative pharmacological burden. The study concludes that contemporary clinical pharmacology must urgently pivot toward individualized, disease-guided glucocorticoid administration to cultivate sustainable disease remission, preserve patient quality of life, and mitigate systemic adverse events in modern rheumatological practice.